TW215090B - - Google Patents

Download PDF

Info

Publication number
TW215090B
TW215090B TW081106530A TW81106530A TW215090B TW 215090 B TW215090 B TW 215090B TW 081106530 A TW081106530 A TW 081106530A TW 81106530 A TW81106530 A TW 81106530A TW 215090 B TW215090 B TW 215090B
Authority
TW
Taiwan
Prior art keywords
compound
patent application
item
ministry
precautions
Prior art date
Application number
TW081106530A
Other languages
English (en)
Chinese (zh)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW215090B publication Critical patent/TW215090B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
TW081106530A 1991-09-25 1992-08-18 TW215090B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25

Publications (1)

Publication Number Publication Date
TW215090B true TW215090B (enExample) 1993-10-21

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081106530A TW215090B (enExample) 1991-09-25 1992-08-18

Country Status (25)

Country Link
US (1) US5565453A (enExample)
EP (1) EP0607163B1 (enExample)
JP (1) JPH08827B2 (enExample)
CN (1) CN1071167A (enExample)
AT (1) ATE146178T1 (enExample)
AU (1) AU655071B2 (enExample)
BR (1) BR9206541A (enExample)
CA (1) CA2118936A1 (enExample)
CZ (1) CZ281775B6 (enExample)
DE (1) DE69215886T2 (enExample)
DK (1) DK0607163T3 (enExample)
ES (1) ES2096099T3 (enExample)
FI (1) FI941377A0 (enExample)
GR (1) GR3022483T3 (enExample)
HU (1) HUT71488A (enExample)
IL (1) IL103204A (enExample)
MX (1) MX9205385A (enExample)
MY (1) MY108303A (enExample)
NO (1) NO941084D0 (enExample)
NZ (1) NZ244473A (enExample)
PL (1) PL170889B1 (enExample)
PT (1) PT100891A (enExample)
TW (1) TW215090B (enExample)
WO (1) WO1993006101A1 (enExample)
ZA (1) ZA927306B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
CZ285090B6 (cs) * 1994-09-30 1999-05-12 Pfizer Inc. 2,7-Disubstituovaný oktahydro-1H-pyrido-[1,2-a]pyrazinové deriváty a farmaceutické prostředky na jejich bázi
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
BRPI0408248A (pt) * 2003-03-12 2006-03-01 Pfizer Prod Inc derivados azabicìclicos de piridiloximetila e de benzisoxazol
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014096212A1 (en) 2012-12-20 2014-06-26 Janssen Pharmaceutica Nv NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
KR102171710B1 (ko) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
JPH06506701A (ja) 1994-07-28
HU9400851D0 (en) 1994-06-28
US5565453A (en) 1996-10-15
NO941084L (no) 1994-03-24
ATE146178T1 (de) 1996-12-15
CN1071167A (zh) 1993-04-21
MY108303A (en) 1996-09-30
CA2118936A1 (en) 1993-04-01
HUT71488A (en) 1995-11-28
AU655071B2 (en) 1994-12-01
CZ395792A3 (en) 1994-05-18
DE69215886T2 (de) 1997-04-03
JPH08827B2 (ja) 1996-01-10
WO1993006101A1 (en) 1993-04-01
CZ281775B6 (cs) 1997-01-15
GR3022483T3 (en) 1997-05-31
FI941377A7 (fi) 1994-03-24
ZA927306B (en) 1994-03-24
DK0607163T3 (da) 1997-03-17
AU2460992A (en) 1993-04-27
NO941084D0 (no) 1994-03-24
PT100891A (pt) 1993-10-29
BR9206541A (pt) 1995-04-25
NZ244473A (en) 1995-04-27
FI941377L (fi) 1994-03-24
MX9205385A (es) 1993-03-01
PL170889B1 (pl) 1997-02-28
IL103204A (en) 1996-05-14
EP0607163A1 (en) 1994-07-27
IL103204A0 (en) 1993-02-21
EP0607163B1 (en) 1996-12-11
DE69215886D1 (de) 1997-01-23
ES2096099T3 (es) 1997-03-01
FI941377A0 (fi) 1994-03-24

Similar Documents

Publication Publication Date Title
JP2514137B2 (ja) キヌクリジン誘導体
JP4898062B2 (ja) アザ二環式カルバメートおよびアルファ−７ニコチン性アセチルコリンレセプターアゴニストとしてのその使用
TW311139B (enExample)
JP4592077B2 (ja) 嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−１（ｎｋ−１）アンタゴニストとしての１−アミド−４−フェニル−４−ベンジルオキシメチル−ピペリジン誘導体および関連化合物
TWI543974B (zh) 苯基－３－氮雜－雙環［３．１．０］己－３－基－甲酮及其作為藥物之用途
JPH05501540A (ja) Ｐｃｐレセプター・リガンドおよびその用途
JPH03176486A (ja) 新規三環式化合物
US5607961A (en) Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
TW200810752A (en) Modulators of muscarinic receptors
JP2008519797A (ja) アザインドールカルボキシアミド類
JP2000212163A (ja) アザシクロオキシムおよびアミンコリン作働剤
TW201141856A (en) (R)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors
JP6483105B2 (ja) ピペラジン誘導体および医薬としてのその使用
JPS62192358A (ja) 置換されたテトラヒドロ―３―ピリジンカルボン酸誘導体およびその製造方法
TWI257392B (en) Isoxazolines derivatives and their use as anti-depressants
JPH05506249A (ja) ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
US5834482A (en) Heterocyclic chemistry
TWI236469B (en) Diamine compound with condensed-ring groups
EA015974B1 (ru) Производные пирролизина, индолизина и хинолизина, их получение и их применение в терапии
JPH09510992A (ja) ブラジキニンアンタゴニストとしてのジヒドロピリジン誘導体
JP2005506280A (ja) アリールおよびアミノアリール置換セロトニン受容体アゴニストおよびアンタゴニストリガンド
JPH09500898A (ja) 中枢神経系活性を有する複素環アミン類
JPH03135980A (ja) 置換ベンゼンの治療学的使用、その製剤および新規な置換ベンゼン
JPH08827B2 (ja) 精神弛緩剤の２−置換パーヒドロ−１Ｈ−ピリド［１，２−ａピラジン
JP2010502760A (ja) うつ病の治療用の３−アザビシクロ［４．１．０］ヘプタン誘導体